Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Remote care platform developer Conversa increased its total funding to more than $26m in a round co-led by Northwell Ventures and backed by UH Ventures.

AstraZeneca and Fresenius Medical Care will exit the kidney disease treatment developer in a $725m acquisition that could potentially rise to $2.1bn.

Novo co-led the series C round with Longitude Capital and Checkmate will use the cash to advance clinical development of its lead asset, which is targeting melanoma.

Francisco Partners has injected $30m into Kyruus, five months after the patient-matching platform developer received $42m in a series D round featuring Salesforce and Providence St Joseph.

Life sciences venture firm 4Bio Capital has secured the biopharmaceutical company as the first strategic backer for its second fund.

Solvay Ventures veteran Alexandre Ouimet-Storrs has joined Mercia alumna Nicola Broughton to form a medical cannabis-focused investment firm.

GCV Rising Star David Schulte has taken up a senior vice-president role to oversee McKesson’s strategic investment arm, after previous unit head Tom Rodgers ascended to chief strategy officer.

Søren Thinggaard Hansen, a 17 year-plus veteran of pension fund Industriens Pension, has joined Novo to launch a private equity program.

Sompo contributed to a $13.5m round for Binah.ai, developer of a mobile app that uses video to assess a user's physical health.